Announcements Trials
Browse Landscape

Phase

Phase NA 6Phase 4 3Phase 3 2Phase 2 1

Status

Completed 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 7Gastrointestinal 7Genitourinary 4CNS 3Breast 3Gynecologic 2Other 1Head & Neck 1Endocrine 1Dermatologic 1

Conditions

Colonic Neoplasms 2Breast Neoplasms 2Rectal Neoplasms 1Prostatic Neoplasms 1Neoplasms 1Melanoma 1Lung Neoplasms 1Female Breast Carcinoma 1

Interventions

Letrozole 23Docetaxel 17Cyclophosphamide 13Zoledronic Acid 12Trastuzumab 12Anastrozole 12exemestane 11Tamoxifen 11Paclitaxel 11Capecitabine 10Fulvestrant 8Epirubicin 8pegfilgrastim 7Saline Solution 7Bupivacaine 7pertuzumab 6liposomal doxorubicin 6abemaciclib 6Sodium Chloride 6Filgrastim 6Carboplatin 6pegylated granulocyte colony-stimulating factor 5palbociclib 5Ropivacaine 5Dexmedetomidine 5Bevacizumab 5ribociclib 4eribulin 4Vinorelbine 4Tranexamic Acid 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 4 × Propofol × Breast × Clear all
NCT01975064 2022-12-14

CAN

Uppsala University

Phase 4 Completed
5,774 enrolled
BreastGastrointestinal

Breast Neoplasms, Colonic Neoplasms, Rectal Neoplasms

NCT04074460 2022-06-09

VAPOR-C

Peter MacCallum Cancer Centre, Australia

Phase 4 Completed
169 enrolled
BreastDermatologicGastrointestinalGenitourinaryThoracic

Breast Neoplasms, Colonic Neoplasms, Lung Neoplasms, Melanoma, Neoplasms, Prostatic Neoplasms

NCT02005770 2020-04-14

Anesthesia and Circulating Tumor Cells in Breast Cancer

University of Zurich

Phase 4 Completed
221 enrolled
Breast

Female Breast Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡